Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study

PURPOSE: To evaluate the safety and tolerability of IgPro20 manual push (also known as rapid push) infusions at flow rates of 0.5–2.0 mL/min. METHODS: Patients with primary immunodeficiency (PID) with previous experience administering IgPro20 (Hizentra(®), CSL Behring, King of Prussia, PA, USA) were...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Immunol
Autori principali: Cowan, Juthaporn, Bonagura, Vincent R., Lugar, Patricia L., Maglione, Paul J., Patel, Niraj C., Vinh, Donald C., Hofmann, Jutta H., Praus, Michaela, Rojavin, Mikhail A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7846525/
https://ncbi.nlm.nih.gov/pubmed/33025378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-020-00876-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi